Ketamine

Questions discussed in this category

What antidepressant medications do you usually use alongside ketamine or esketamine treatment in patients with difficult-to-treat depression?

In your clinical practice, have you noticed whether concurrent pharmacotherapy improves the durability of ketamine’s effects? Which medications ...

2 Answers available

When do you refer a patient with difficult-to-treat depression for esketamine nasal spray versus IV ketamine treatment?

What clinical factors influence your decision? Are there specific practice settings or insurance considerations that push you toward one option over t...

3 Answers available

When do you refer patients with difficult-to-treat depression for ECT rather than other interventional psychiatric treatments, such as TMS or esketamine?

2 Answers available

How do you determine the treatment course of esketamine or IV ketamine when used for treatment-resistant major depressive disorder?

1 Answer available

Papers discussed in this category

Biological psychiatry, 2010-01-15

Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression.

Molecular psychiatry, 2018-10-03

Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD).

Journal of affective disorders, 2020 Jul 21

The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis.

The Journal of clinical psychiatry, 2023 Feb 01

Comparative Effectiveness of Intravenous Ketamine and Intranasal Esketamine in Clinical Practice Among Patients With Treatment-Refractory Depression: An Observational Study.

CNS drugs, 2023 Aug 09

Efficacy and Safety of Esketamine Nasal Spray in Patients with Treatment-Resistant Depression Who Completed a Second Induction Period: Analysis of the Ongoing SUSTAIN-3 Study.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2023 May 12

Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study.

Psychotherapy and psychosomatics, 2017 May 11

Cognitive Behavior Therapy May Sustain Antidepressant Effects of Intravenous Ketamine in Treatment-Resistant Depression.

Ketamine

Questions discussed in this category

Papers discussed in this category

Related Topics